Literature DB >> 17372003

T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.

Naeem Khan1, Donna Best, Rachel Bruton, Laxman Nayak, Alan B Rickinson, Paul A H Moss.   

Abstract

Replication of human cytomegalovirus is controlled by a vigorous CD8 T cell response. The persistent nature of infection is believed to periodically stimulate T cell responses resulting in considerable expansions of virus-specific CD8 T cells over time. In this study, we describe the magnitude and breadth of CD8 T cell responses against the immunodominant viral Ags, IE-1 and pp65, in acute and long-term infection using the IFN-gamma ELISPOT assay. Simultaneously, we have identified several novel MHC class I restricted CD8 T cell epitopes. Acute phase responses in immunocompetent donors appear to be extremely focused as early as 1 week post diagnosis with dominant peptide-specific responses observed against both proteins. These dominant responses remain detectable at all later time points over a 4-year follow-up. Interestingly the IE-1 responses show an increase over time whereas the pp65 responses do not, which contrasts with data showing that responses against both Ags are elevated in elderly individuals. We also observe the rapid emergence of an effector memory phenotype for virus-specific CD8 T cells as observed in persistent infection. Over time the revertant CD45RA(pos) effector cell population is also expanded, and this is more evident in the preferentially expanded IE-1 responses. We postulate that periodic low-level virus reactivation after the acute infection phase preferentially stimulates these responses whereas pp65-specific T cell expansions probably occur during the infrequent episodes of lytic viral replication or secondary infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372003     DOI: 10.4049/jimmunol.178.7.4455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.

Authors:  Raskit Lachmann; Martha Bajwa; Serena Vita; Helen Smith; Elizabeth Cheek; Arne Akbar; Florian Kern
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.

Authors:  L E Higdon; J Trofe-Clark; S Liu; K B Margulies; M K Sahoo; E Blumberg; B A Pinsky; J S Maltzman
Journal:  Am J Transplant       Date:  2017-03-13       Impact factor: 8.086

3.  Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.

Authors:  Nina Babel; Gordon Brestrich; Lukasz P Gondek; Arne Sattler; Marcin W Wlodarski; Nina Poliak; Nicole Bethke; Andreas Thiel; Markus H Hammer; Petra Reinke; Jaroslaw P Maciejewski
Journal:  J Am Soc Nephrol       Date:  2008-09-17       Impact factor: 10.121

4.  Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.

Authors:  Lei Bao; Kimberly Dunham; Mindy Stamer; Kevin M Mulieri; Kenneth G Lucas
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

5.  Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.

Authors:  Xiangfeng He; Jing Wang; Fengshu Zhao; Fangliu Yu; Dengyu Chen; Kai Cai; Cuiping Yang; Junsong Chen; Jun Dou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

6.  Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.

Authors:  Corey Smith; Rebekah M Brennan; Siok-Keen Tey; Mark J Smyth; Scott R Burrows; John J Miles; Geoffrey R Hill; Rajiv Khanna
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

Review 8.  Novel strategies for adoptive therapy following HLA disparate transplants.

Authors:  Richard J O'Reilly; Aisha Hasan; Ekaterina Doubrovina; Guenther Koehne; Susan Prockop
Journal:  Best Pract Res Clin Haematol       Date:  2011-09       Impact factor: 3.020

9.  Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.

Authors:  Ulrike Gerdemann; Laura Keukens; Jacqueline M Keirnan; Usha L Katari; Chinh T Q Nguyen; Anne P de Pagter; Carlos A Ramos; Alana Kennedy-Nasser; Stephen M Gottschalk; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Ann M Leen
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

10.  Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.

Authors:  Jong-Baeck Lim; Hyun Ok Kim; Seok Hoon Jeong; Joo Eun Ha; Sunphil Jang; Sang-Guk Lee; Kyungwon Lee; David Stroncek
Journal:  J Transl Med       Date:  2009-08-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.